J&J opts out of new wellness unit

All's well that ends well? Johnson & Johnson has decided not to launch a stand-alone wellness and disease-prevention unit. Instead, it's planning to expand its business in that area under the umbrella of its consumer unit. Last year, J&J announced its wellness intentions with the acquisition of HealthMedia, saying that it hoped the new unit would account for $20 billion in revenue. Report

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.